MedTrace Logo

Radiofrequency Ablation in Patients With Barrett's Esophagus

NCT02793479 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-07-05

No results posted yet for this study

Summary

The aim of this study is to establish a nationwide registry to collect data regarding the treatment of Barrett's Esophagus (BE) with radiofrequency ablation. The objective of this registry is to increase the number of data and therefore obtain a raise of quality assurance and improve outcome and patient security. Furthermore to provide participating physicians information and experience for treatment details in the therapy of BE.

Conditions

  • Barrett's Esophagus
  • Radiofrequency Ablation
  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY

  • Matthias Paireder

    lead OTHER

Principal Investigators

  • Sebastian F Schoppmann, MD · Medical University of Vienna

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793479 on ClinicalTrials.gov